Biomarker Type: Genomic
-
Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials
-
Development of new droplet digital PCR method for MSI assessment with automated analysis pipeline shows concordance in FFPE and plasma
-
Evaluation of two clinically focused targeted NGS systems for liquid biopsy testing shows a high level of concordance in resulting actionable mutations
-
Prevalence of four major gene mutation classes in a survey of ctDNA recovery from early and advanced stage NSCLC specimens
-
Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variant
-
Turnaround Time and Variant Prevalence of a Blood-based KRAS Test in patients with NSCLC
-
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
-
Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC
-
Profiling the TCR beta repertoire in liquid biopsies from NSCLC donors
-
Validation of the EGFR Uncommon Variants Multiplex ddPCR Assay for Blood-Based Testing in NSCLC